Dexrazoxane
NDC 68083-195, Dexrazoxane for Injection, injection, powder, lyophilized, for solution, from Gland Pharma Limited.
- Product NDC
- 68083-195
- Status
- Listed
- Labeler
- Gland Pharma Limited
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207321
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68083-195 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEXRAZOXANE HYDROCHLORIDE500 mg/50mL
Pharmacologic classes
Cytoprotective Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68083-195-01 | 68083019501 | 1 VIAL in 1 CARTON (68083-195-01) / 50 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c9c625fc-8852-4ed4-bcf2-63f46a706782
Use it
Look up 68083-195 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68083-195 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68083-195. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.